OSE Immunotherapeutics S.A.
OSE.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€15,105 | -€19,730 | €57,175 | -€11,143 |
| Dep. & Amort. | €1,632 | €0 | €1,664 | €1,729 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €0 | €0 | €0 | €472 |
| Change in WC | -€2,590 | -€5,597 | €7,577 | €303 |
| Other Non-Cash | -€1,919 | €6,665 | €217 | €602 |
| Operating Cash Flow | -€17,982 | -€18,193 | €66,633 | -€8,037 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€9 | -€59 | -€18 | -€16 |
| Net Acquisitions | €0 | €0 | €0 | -€62 |
| Inv. Purchases | -€21 | -€46,561 | -€6 | -€275 |
| Inv. Sales/Matur. | €0 | €0 | €0 | €0 |
| Other Inv. Act. | €30,400 | €54,625 | -€54,890 | -€264 |
| Investing Cash Flow | €30,370 | €8,005 | -€54,914 | -€617 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€3,376 | €992 | -€4,328 | €1,308 |
| Stock Issued | €0 | €942 | €215 | €11,170 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€364 | -€389 | -€421 | -€169 |
| Financing Cash Flow | -€3,740 | €1,545 | -€4,534 | €12,309 |
| Forex Effect | €1 | -€49,889 | €49,889 | -€1 |
| Net Chg. in Cash | €8,649 | -€59,001 | €57,074 | €3,654 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €16,745 | €75,746 | €18,672 | €15,018 |
| End Cash | €25,394 | €16,745 | €75,746 | €18,672 |
| Free Cash Flow | -€17,991 | -€18,252 | €66,615 | -€8,053 |